Since April 2020, the ACT-Accelerator partnership has supported the fastest, most coordinated, and successful global effort in history to develop tools to fight a disease. The ACT-Accelerator has driven real progress, delivering diagnostic tests, repurposed treatments, and vaccines.
By the end of 2021, the ACT-Accelerator aims to deliver at least 900 million diagnostic tests, 100 million courses of treatment and 2 billion doses of vaccine to low- and middle-income countries.
Yet inequity in access to COVID-19 tools remains unacceptably high, and new variants of concern continue to emerge around the globe. There is still much more to be done to fight this virus. Only united and through a comprehensive approach of all these interventions and tools can we defeat COVID-19.